These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 26539647
1. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients. Yılmaz I, Ozkok A, Kostek O, Kolukısa A, Duran I, Odabaş AR, Kemal Işman F, Işbilen Başok B. Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647 [Abstract] [Full Text] [Related]
2. High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study. Panichi V, Scatena A, Rosati A, Giusti R, Ferro G, Malagnino E, Capitanini A, Piluso A, Conti P, Bernabini G, Migliori M, Caiani D, Tetta C, Casani A, Betti G, Pizzarelli F. Nephrol Dial Transplant; 2015 Apr; 30(4):682-9. PubMed ID: 25385719 [Abstract] [Full Text] [Related]
3. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Petrulienė K, Žiginskienė E, Kuzminskis V, Nedzelskienė I, Bumblytė IA. Medicina (Kaunas); 2017 Apr; 53(2):90-100. PubMed ID: 28416170 [Abstract] [Full Text] [Related]
12. Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter? Yigit IP, Celiker H, Dogukan A, Ilhan N, Gurel A, Ulu R, Aygen B. Ren Fail; 2015 Feb; 37(1):77-82. PubMed ID: 25347233 [Abstract] [Full Text] [Related]
15. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T. Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178 [Abstract] [Full Text] [Related]
16. Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study. Ogawa T, Shimizu H, Kyono A, Sato M, Yamashita T, Otsuka K, Nitta K. Int Urol Nephrol; 2014 Jan; 46(1):151-9. PubMed ID: 23807369 [Abstract] [Full Text] [Related]
17. ESA Hyporesponsiveness Is Associated with Adverse Events in Maintenance Hemodialysis (MHD) Patients, But Not with Iron Storage. Kuragano T, Kitamura K, Matsumura O, Matsuda A, Hara T, Kiyomoto H, Murata T, Fujimoto S, Hase H, Joki N, Fukatsu A, Inoue T, Itakura Y, Nakanishi T. PLoS One; 2016 Jan; 11(3):e0147328. PubMed ID: 26933949 [Abstract] [Full Text] [Related]